LXRX LEXICON PHARMACEUTICALS, INC.
Nasdaq · SEC CIK 1062822 · EDGAR
- Bought, last 12 months
- $2.72M 5 purchases by 2 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 189 since 2021-08-03, latest 2026-06-04 16:14
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Artal Group S.A. | Dir, 10% | $2.00M | — |
| DEBBANE RAYMOND | Dir | $723.0K | — |
| Martens Rachel Yap | SVP, Partnerships, Corp Strat | — | — |
| Gopinathan Suma | SVP, Discovery | — | — |
| Artal Participations S.a r.l. | Dir, 10% | — | — |
| Cheung Ivan | Dir | — | — |
| Exton Michael | CEO, Dir | — | — |
| Sullivan Diane E. | Dir | — | — |
| McDermott Wendy | SVP, Human Resources | — | — |
| Granowitz Craig B | SVP, Chief Medical Off | — | — |
Transactions 138
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-04 16:14 | 2026-06-03 | LXRX | Swain Judith L | Dir | M - OptEx | $0.00 | +89.3K | 174.5K | +105% | $0 |
| D | 2026-06-04 16:13 | 2026-06-03 | LXRX | Sullivan Diane E. | Dir | M - OptEx | $0.00 | +89.3K | 126.1K | +243% | $0 |
| D | 2026-06-04 16:13 | 2026-06-03 | LXRX | SOBECKI CHRISTOPHER J | Dir | M - OptEx | $0.00 | +89.3K | 293.2K | +44% | $0 |
| D | 2026-06-04 16:12 | 2026-06-03 | LXRX | Cheung Ivan | Dir | M - OptEx | $0.00 | +89.3K | 89.3K | New | $0 |
| D | 2026-06-04 16:11 | 2026-06-03 | LXRX | BARKER SAM L | Dir | M - OptEx | $0.00 | +89.3K | 213.8K | +72% | $0 |
| D | 2026-06-04 16:10 | 2026-06-03 | LXRX | Amouyal Philippe | Dir | M - OptEx | $0.00 | +89.3K | 374.5K | +31% | $0 |
| D | 2026-06-04 16:09 | 2026-06-03 | LXRX | DEBBANE RAYMOND | Dir | M - OptEx | $0.00 | +89.3K | 2.00M | +5% | $0 |
| DI | 2026-05-08 21:45 | 2026-04-30 | LXRX | Artal Participations S.a r.l. | Dir, 10% | M - OptEx | $0.00 | +20.42M | 175.16M | +13% | $0 |
| DM | 2026-03-03 | 2026-02-28 | LXRX | Granowitz Craig B | SVP, Chief Medical Off | M - OptEx | — | +312.3K | 432.5K | +260% | — |
| D | 2026-03-03 | 2026-02-28 | LXRX | Granowitz Craig B | SVP, Chief Medical Off | F - Tax | $1.47 | -109.1K | 323.4K | -25% | -$160.4K |
| DM | 2026-03-03 | 2026-02-28 | LXRX | Crum Brian T | SVP, GC, Secr | M - OptEx | — | +273.0K | 330.2K | +477% | — |
| D | 2026-03-03 | 2026-02-28 | LXRX | Crum Brian T | SVP, GC, Secr | F - Tax | $1.47 | -105.0K | 428.8K | -20% | -$154.4K |
| DM | 2026-03-03 | 2026-02-28 | LXRX | McDermott Wendy | SVP, Human Resources | M - OptEx | — | +224.4K | 346.1K | +184% | — |
| D | 2026-03-03 | 2026-02-28 | LXRX | McDermott Wendy | SVP, Human Resources | F - Tax | $1.47 | -68.1K | 277.9K | -20% | -$100.1K |
| D | 2026-03-03 | 2026-02-28 | LXRX | Exton Michael | CEO, Dir | F - Tax | $1.47 | -204.8K | 298.4K | -41% | -$301.1K |
| D | 2026-03-03 | 2026-02-28 | LXRX | Exton Michael | CEO, Dir | M - OptEx | — | +503.3K | 503.3K | New | — |
| D | 2026-03-03 | 2026-02-28 | LXRX | Martens Rachel Yap | SVP, Partnerships, Corp Strat | F - Tax | $1.47 | -35.8K | 31.3K | -53% | -$52.7K |
| D | 2026-03-03 | 2026-02-28 | LXRX | Martens Rachel Yap | SVP, Partnerships, Corp Strat | M - OptEx | — | +67.1K | 67.1K | New | — |
| D | 2026-03-03 | 2026-02-28 | LXRX | DeFrancesco Lisa | SVP, IR, Corp Comm | F - Tax | $1.47 | -74.6K | 93.9K | -44% | -$109.6K |
| DM | 2026-03-03 | 2026-02-28 | LXRX | DeFrancesco Lisa | SVP, IR, Corp Comm | M - OptEx | — | +152.9K | 40.3K | New | — |
| D | 2026-03-03 | 2026-02-28 | LXRX | Coiante Scott M | SVP, CFO | M - OptEx | — | +160.2K | 160.2K | New | — |
| D | 2026-03-03 | 2026-02-28 | LXRX | Coiante Scott M | SVP, CFO | F - Tax | $1.47 | -54.9K | 105.4K | -34% | -$80.7K |
| DM | 2026-03-03 | 2026-02-28 | LXRX | Gopinathan Suma | SVP, Discovery | M - OptEx | — | +100.0K | 88.5K | New | — |
| D | 2026-03-03 | 2026-02-28 | LXRX | Gopinathan Suma | SVP, Discovery | F - Tax | $1.47 | -24.3K | 150.1K | -14% | -$35.8K |
| 2026-02-27 | 2026-02-25 | LXRX | DEBBANE RAYMOND | Dir | P - Purchase | $1.49 | +2,000 | 1.91M | +0.1% | +$2,980 | |
| 2026-02-25 | 2026-02-23 | LXRX | DEBBANE RAYMOND | Dir | P - Purchase | $1.47 | +100.0K | 1.90M | +6% | +$147.0K | |
| M | 2026-02-23 | 2026-02-19+ | LXRX | DEBBANE RAYMOND | Dir | P - Purchase | $1.47 | +150.0K | 1.70M | +10% | +$220.0K |
| I | 2026-02-19 | 2026-02-17 | LXRX | Artal International S.C.A. | Dir, 10% | A - Grant | $65.00 | +41.3K | 408.4K | +11% | +$2.68M |
| M | 2026-02-18 | 2026-02-13+ | LXRX | DEBBANE RAYMOND | Dir | P - Purchase | $1.31 | +268.5K | 1.65M | +19% | +$353.1K |
| I | 2026-02-04 | 2026-02-02 | LXRX | Artal Group S.A. | Dir, 10% | P - Purchase | $1.30 | +1.54M | 1.54M | New | +$2.00M |
| MI | 2026-02-04 | 2026-02-02 | LXRX | Artal Group S.A. | Dir, 10% | A - Grant | $2.33 | +22.77M | 367.1K | New | +$52.98M |
| D | 2025-05-13 | 2025-05-13 | LXRX | DEBBANE RAYMOND | Dir | M - OptEx | $0.00 | +36.8K | 1.39M | +3% | $0 |
| D | 2025-05-13 | 2025-05-13 | LXRX | Amouyal Philippe | Dir | M - OptEx | $0.00 | +36.8K | 285.2K | +15% | $0 |
| D | 2025-05-13 | 2025-05-13 | LXRX | Sullivan Diane E. | Dir | M - OptEx | $0.00 | +36.8K | 36.8K | New | $0 |
| D | 2025-05-13 | 2025-05-13 | LXRX | Swain Judith L | Dir | M - OptEx | $0.00 | +36.8K | 85.2K | +76% | $0 |
| D | 2025-05-13 | 2025-05-13 | LXRX | BARKER SAM L | Dir | M - OptEx | $0.00 | +36.8K | 124.5K | +42% | $0 |
| D | 2025-05-13 | 2025-05-13 | LXRX | SOBECKI CHRISTOPHER J | Dir | M - OptEx | $0.00 | +36.8K | 203.9K | +22% | $0 |
| DM | 2025-03-03 | 2025-02-28 | LXRX | Alexander Kristen | VP, Fin, Accounting | M - OptEx | — | +46.4K | 94.2K | +97% | — |
| D | 2025-03-03 | 2025-02-28 | LXRX | Alexander Kristen | VP, Fin, Accounting | F - Tax | $0.67 | -17.9K | 76.4K | -19% | -$12.0K |
| DM | 2025-03-03 | 2025-02-28 | LXRX | Granowitz Craig B | SVP, Chief Medical Off | M - OptEx | — | +137.9K | 75.5K | New | — |
| D | 2025-03-03 | 2025-02-28 | LXRX | Granowitz Craig B | SVP, Chief Medical Off | F - Tax | $0.67 | -65.3K | 120.3K | -35% | -$43.8K |
| DM | 2025-03-03 | 2025-02-28 | LXRX | McDermott Wendy | SVP, Human Resources | M - OptEx | — | +99.0K | 151.7K | +188% | — |
| D | 2025-03-03 | 2025-02-28 | LXRX | McDermott Wendy | SVP, Human Resources | F - Tax | $0.67 | -30.0K | 121.6K | -20% | -$20.1K |
| D | 2025-03-03 | 2025-02-28 | LXRX | MAIN ALAN J | EVP, Innov, Chem Sciences | F - Tax | $0.67 | -43.4K | 339.1K | -11% | -$29.1K |
| DM | 2025-03-03 | 2025-02-28 | LXRX | MAIN ALAN J | EVP, Innov, Chem Sciences | M - OptEx | — | +126.8K | 281.4K | +82% | — |
| D | 2025-03-03 | 2025-02-28 | LXRX | DeFrancesco Lisa | SVP, IR, Corp Comm | F - Tax | $0.67 | -9,096 | 15.6K | -37% | -$6,094 |
| D | 2025-03-03 | 2025-02-28 | LXRX | DeFrancesco Lisa | SVP, IR, Corp Comm | M - OptEx | — | +24.7K | 24.7K | New | — |
| DM | 2025-03-03 | 2025-02-28 | LXRX | Crum Brian T | SVP, GC, Secr | M - OptEx | — | +128.9K | 306.4K | +73% | — |
| D | 2025-03-03 | 2025-02-28 | LXRX | Crum Brian T | SVP, GC, Secr | F - Tax | $0.67 | -45.6K | 260.8K | -15% | -$30.6K |
| DI | 2024-05-14 | 2024-05-10 | LXRX | Artal Group S.A. | Dir, 10% | M - OptEx | — | +57.55M | 136.18M | +73% | — |
| D | 2024-04-29 | 2024-04-28 | LXRX | BARKER SAM L | Dir | M - OptEx | $0.00 | +8,032 | 87.6K | +10% | $0 |
| D | 2024-04-29 | 2024-04-28 | LXRX | SOBECKI CHRISTOPHER J | Dir | M - OptEx | $0.00 | +8,032 | 167.1K | +5% | $0 |
| D | 2024-04-29 | 2024-04-28 | LXRX | Swain Judith L | Dir | M - OptEx | $0.00 | +8,032 | 48.4K | +20% | $0 |
| D | 2024-04-29 | 2024-04-28 | LXRX | DEBBANE RAYMOND | Dir | M - OptEx | $0.00 | +8,032 | 1.35M | +0.6% | $0 |
| D | 2024-04-29 | 2024-04-28 | LXRX | Amouyal Philippe | Dir | M - OptEx | $0.00 | +8,032 | 248.4K | +3% | $0 |
| D | 2024-04-29 | 2024-04-28 | LXRX | LEFKOWITZ ROBERT J MD | Dir | M - OptEx | $0.00 | +8,032 | 48.4K | +20% | $0 |
| I | 2024-03-13 | 2024-03-13 | LXRX | Stichting Administratiekantoor Westend | Dir, 10% | A - Grant | $108.50 | +1.15M | 1.15M | New | +$124.88M |
| DM | 2024-02-29 | 2024-02-28 | LXRX | COATS LONNEL | CEO, Dir | M - OptEx | — | +245.1K | 947.7K | +35% | — |
| D | 2024-02-29 | 2024-02-28 | LXRX | COATS LONNEL | CEO, Dir | F - Tax | $2.62 | -61.4K | 1.10M | -5% | -$160.8K |
| D | 2024-02-29 | 2024-02-28 | LXRX | Granowitz Craig B | SVP, Chief Medical Off | F - Tax | $2.62 | -31.3K | 47.6K | -40% | -$81.9K |
| DM | 2024-02-29 | 2024-02-28 | LXRX | Granowitz Craig B | SVP, Chief Medical Off | M - OptEx | — | +63.7K | 78.9K | +420% | — |
| D | 2024-02-29 | 2024-02-28 | LXRX | McDermott Wendy | VP, Human Resources | F - Tax | $2.62 | -22.4K | 52.7K | -30% | -$58.8K |
| DM | 2024-02-29 | 2024-02-28 | LXRX | McDermott Wendy | VP, Human Resources | M - OptEx | — | +46.6K | 47.4K | +5,972% | — |
| D | 2024-02-29 | 2024-02-28 | LXRX | WADE JEFFREY L | Pres, CFO | F - Tax | $2.62 | -37.7K | 324.2K | -10% | -$98.8K |
| DM | 2024-02-29 | 2024-02-28 | LXRX | WADE JEFFREY L | Pres, CFO | M - OptEx | — | +97.6K | 361.9K | +37% | — |
| DM | 2024-02-29 | 2024-02-28 | LXRX | MAIN ALAN J | EVP, Innov, Chem Sciences | M - OptEx | — | +67.5K | 247.2K | +38% | — |
| D | 2024-02-29 | 2024-02-28 | LXRX | MAIN ALAN J | EVP, Innov, Chem Sciences | F - Tax | $2.62 | -24.4K | 255.7K | -9% | -$63.9K |
| D | 2024-02-29 | 2024-02-28 | LXRX | Alexander Kristen | VP, Fin, Accounting | F - Tax | $2.62 | -11.8K | 47.8K | -20% | -$30.9K |
| DM | 2024-02-29 | 2024-02-28 | LXRX | Alexander Kristen | VP, Fin, Accounting | M - OptEx | — | +29.2K | 59.6K | +96% | — |
| DM | 2024-02-29 | 2024-02-28 | LXRX | Kassler-Taub Kenneth B. | SVP, Regulatory, QA | M - OptEx | — | +67.4K | 126.7K | +114% | — |
| D | 2024-02-29 | 2024-02-28 | LXRX | Kassler-Taub Kenneth B. | SVP, Regulatory, QA | F - Tax | $2.62 | -24.4K | 162.7K | -13% | -$63.8K |
| D | 2024-02-29 | 2024-02-28 | LXRX | Crum Brian T | SVP, GC, Secr | F - Tax | $2.62 | -25.6K | 177.5K | -13% | -$67.1K |
| DM | 2024-02-29 | 2024-02-28 | LXRX | Crum Brian T | SVP, GC, Secr | M - OptEx | — | +68.3K | 143.5K | +91% | — |
| 2023-11-17 | 2023-11-16 | LXRX | COATS LONNEL | CEO, Dir | P - Purchase | $1.05 | +90.0K | 914.4K | +11% | +$94.5K | |
| 2023-11-14 | 2023-11-13 | LXRX | Amouyal Philippe | Dir | P - Purchase | $1.01 | +200.0K | 240.3K | +496% | +$202.0K | |
| 2023-11-13 | 2023-11-10 | LXRX | COATS LONNEL | CEO, Dir | P - Purchase | $1.01 | +10.0K | 824.4K | +1% | +$10.1K | |
| M | 2023-10-12 | 2023-10-10+ | LXRX | DEBBANE RAYMOND | Dir | P - Purchase | $1.10 | +1.00M | 1.19M | +521% | +$1.10M |
| 2023-09-14 | 2023-09-14 | LXRX | WADE JEFFREY L | Pres, CFO | P - Purchase | $1.38 | +10.0K | 264.3K | +4% | +$13.8K | |
| 2023-08-07 | 2023-08-04 | LXRX | McDermott Wendy | VP, Human Resources | P - Purchase | $1.84 | +6,000 | 28.5K | +27% | +$11.0K | |
| 2023-06-29 | 2023-06-29 | LXRX | COATS LONNEL | CEO, Dir | P - Purchase | $2.16 | +10.0K | 814.4K | +1% | +$21.6K | |
| 2023-06-27 | 2023-06-23 | LXRX | McDermott Wendy | VP, Human Resources | P - Purchase | $2.43 | +10.0K | 22.5K | +80% | +$24.3K | |
| M | 2023-06-26 | 2023-06-23+ | LXRX | COATS LONNEL | CEO, Dir | P - Purchase | $2.34 | +20.0K | 804.4K | +3% | +$46.8K |
| 2023-06-22 | 2023-06-22 | LXRX | COATS LONNEL | CEO, Dir | P - Purchase | $2.31 | +40.0K | 784.4K | +5% | +$92.4K | |
| M | 2023-06-20 | 2023-06-20 | LXRX | WADE JEFFREY L | Pres, CFO | P - Purchase | $2.34 | +12.0K | 252.3K | +5% | +$28.1K |
| I | 2023-06-05 | 2023-06-05 | LXRX | Artal Group S.A. | Dir, 10% | P - Purchase | $2.60 | +27.78M | 78.63M | +55% | +$72.22M |
| D | 2023-05-22 | 2023-05-21 | LXRX | LEFKOWITZ ROBERT J MD | Dir | M - OptEx | $0.00 | +9,302 | 40.3K | +30% | $0 |
| D | 2023-05-22 | 2023-05-21 | LXRX | Swain Judith L | Dir | M - OptEx | $0.00 | +9,302 | 40.3K | +30% | $0 |
| D | 2023-05-22 | 2023-05-21 | LXRX | BARKER SAM L | Dir | M - OptEx | $0.00 | +9,302 | 79.6K | +13% | $0 |
| D | 2023-05-22 | 2023-05-21 | LXRX | NIES ALAN S | Dir | M - OptEx | $0.00 | +9,302 | 41.0K | +29% | $0 |
| D | 2023-05-22 | 2023-05-21 | LXRX | DEBBANE RAYMOND | Dir | M - OptEx | $0.00 | +9,302 | 340.8K | +3% | $0 |
| D | 2023-05-22 | 2023-05-21 | LXRX | Palantoni Frank | Dir | M - OptEx | $0.00 | +9,302 | 40.3K | +30% | $0 |
| D | 2023-05-22 | 2023-05-21 | LXRX | Amouyal Philippe | Dir | M - OptEx | $0.00 | +9,302 | 40.3K | +30% | $0 |
| D | 2023-05-22 | 2023-05-21 | LXRX | SOBECKI CHRISTOPHER J | Dir | M - OptEx | $0.00 | +9,302 | 159.0K | +6% | $0 |
| D | 2023-03-01 | 2023-02-28 | LXRX | COATS LONNEL | CEO, Dir | F - Tax | $2.17 | -51.0K | 744.4K | -6% | -$110.6K |
| DM | 2023-03-01 | 2023-02-28 | LXRX | COATS LONNEL | CEO, Dir | M - OptEx | — | +209.3K | 795.3K | +36% | — |
| DM | 2023-03-01 | 2023-02-28 | LXRX | Crum Brian T | SVP, GC, Secr | M - OptEx | — | +55.9K | 155.3K | +56% | — |
| D | 2023-03-01 | 2023-02-28 | LXRX | Crum Brian T | SVP, GC, Secr | F - Tax | $2.17 | -20.5K | 134.8K | -13% | -$44.6K |
| DM | 2023-03-01 | 2023-02-28 | LXRX | WADE JEFFREY L | Pres, CFO | M - OptEx | — | +78.9K | 272.6K | +41% | — |
| D | 2023-03-01 | 2023-02-28 | LXRX | WADE JEFFREY L | Pres, CFO | F - Tax | $2.17 | -30.3K | 242.3K | -11% | -$65.7K |
| D | 2023-03-01 | 2023-02-28 | LXRX | McDermott Wendy | VP, Human Resources | M - OptEx | — | +18.9K | 18.9K | New | — |
Purchase Sale Sale after option exercise All abbreviations